Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Gray, W; Bayer-Pietsch, E; Chieco, P; Cochand Priollet, B; Desai, M; Drijkoningen, M; Griffin, M; Hagmar, B; Kapila, K; Kloboves-Prevodnik, V; Kobayashi, T; Krogerus, L; Majak, B; Mihailovici, M; Olszewski, W; Schenck, U; Schmitt, F; Shabalova, I; Shapiro, N; Smith, J; Tani, E; Totsch, M; Vass, L; Wiener, H; Herbert, A.
The future of cytopathology in Europe. Will the wider use of HPV testing have an impact on the provision of cervical screening?
Cytopathology. 2007; 18(5):278-282
Doi: 10.1111/j.1365-2303.2007.00487.x
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Tötsch Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The emphasis of the EFCS Congress held in Venice in October 2006 was on the future of Cytopathology in relation to events in Europe. Much of the discussion centred on the role of human papilloma virus testing and its impact on the provision of cervical screening. The following is a transcript of the discussion that took place at the Advisory Board Meeting for the journal Cytopathology, with some additional written comments received prior to the meeting. A brief summary has been provided as a conclusion by Dr A. Herbert.
- Find related publications in this database (using NLM MeSH Indexing)
-
Cytological Techniques -
-
Europe -
-
Female -
-
Humans -
-
Mass Screening - methods
-
Papillomaviridae - isolation and purification
-
Papillomavirus Infections - diagnosis
-
Pathology, Clinical - methods
-
Uterine Cervical Neoplasms - prevention and control Uterine Cervical Neoplasms - virology
- Find related publications in this database (Keywords)
-
cervical screening
-
HPV testing
-
training
-
quality control
-
triage
-
cytology
-
European experience